Professor Zuzana Motovska

no speaker photo

Speaker

Zuzana Motovska

Charles University of Prague, Prague (Czechia)

Specialities : Acute Coronary Syndromes , Acute Cardiac Care, Acute Coronary Syndromes

Follow me on:

9 presentations from this speaker

Dual antithrombotic therapy is similarly effective to triple therapy in preventing thrombotic events in patients with atrial fibrillation and acute coronary syndrome

Event : ESC Congress 2019

Session : Atrial fibrillation and oral anticoagulation 5
Speaker : Z Motovska (Prague,CZ)

MiR-126-3P and MiR-223-3p in Prediction of Thrombotic Risk in Patients with Acute Myocardial Infarction and Primary Angioplasty, The Prague-18 Genetic Sub-study

Event : ESC Congress 2019

Session : Cardiac troponins and other biomarkers in acute coronary syndromes
Speaker : Z Motovska (Prague,CZ)

Predictors and case fatality rate of perioperative major cardiovascular events in cardiac patients undergoing non-cardiac surgery.

Event : ESC Congress 2017

Session : Risk estimation in high risk individuals
Speaker : Z Motovska (Prague,CZ)

Administration of intravenous fentanyl and laboratory efficacy of new p2y12 receptor antagonists in patients with STE myocardial infarction

Event : Acute Cardiovascular Care 2015

Session : Antithrombotic therapy
Speaker : Z Motovska (Prague,CZ)

Number of severe bleeding complications according to classification used: is unified classification of bleeding complications really necessary?

Event : ESC Congress 2015

Session : Understanding the risks and optimising outcomes after PCI II
Speaker : Z Motovska (Prague,CZ)

The Killip classification in prediction of laboratory efficacy Of P2Y12 receptor inhibitors in patients with STE myocardial infarction

Event : ESC Congress 2015

Session : Infarction acute phase STEMI IV
Speaker : Z Motovska (Prague,CZ)

Comparison of laboratory efficacy of P2Y12 receptor antagonists and predictors of high on-treatment platelet reactivity.

Event : ESC Congress 2014

Session : Percutaneous coronary intervention and antiplatelet therapy
Speaker : Z Motovska (Prague,CZ)

Dose of aspirin does not inluence laboratory antiplatelet efficacy of P2Y12 inhibitors

Event : ESC Congress 2013

Session : Thrombosis and antithrombotic therapy
Speaker : Z Motovska (Prague,CZ)

Values of osteoprotegerin in aortic valve tissue differ significantly between calcified aortic valve stenosis and normal aortic valve and are influenced by the presence of coronary atherosclerosis

Event : ESC Congress 2013

Session : Basics in valvular heart disease
Speaker : Z Motovska (Prague,CZ)

Members get more

1ESC Professional Members – access all resources from general ESC events
2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
3Under 40 or in training - with a Combined Membership, access all resources

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

Our mission: To reduce the burden of cardiovascular disease